MERCK KGAA NAM.SP.ADR - Asset Resilience Ratio

Latest as of December 2025: 1.16%

MERCK KGAA NAM.SP.ADR (MRKC) has an Asset Resilience Ratio of 1.16% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MRKC working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€597.00 Million
≈ $697.96 Million USD Cash + Short-term Investments

Total Assets

€51.53 Billion
≈ $60.24 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how MERCK KGAA NAM.SP.ADR's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MERCK KGAA NAM.SP.ADR assets under control.

Liquid Assets Composition Over Time

This chart breaks down MERCK KGAA NAM.SP.ADR's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read MRKC total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €597.00 Million 1.16%
Total Liquid Assets €597.00 Million 1.16%

Asset Resilience Insights

  • Limited Liquidity: MERCK KGAA NAM.SP.ADR maintains only 1.16% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

MERCK KGAA NAM.SP.ADR Industry Peers by Asset Resilience Ratio

Compare MERCK KGAA NAM.SP.ADR's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 0.50%
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Neuland Laboratories Limited
NSE:NEULANDLAB
Drug Manufacturers - Specialty & Generic 9.65%
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
Drug Manufacturers - Specialty & Generic 1.18%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%

Annual Asset Resilience Ratio for MERCK KGAA NAM.SP.ADR (2020–2025)

The table below shows the annual Asset Resilience Ratio data for MERCK KGAA NAM.SP.ADR.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.16% €597.00 Million
≈ $697.96 Million
€51.53 Billion
≈ $60.24 Billion
+0.08pp
2024-12-31 1.08% €558.00 Million
≈ $652.36 Million
€51.57 Billion
≈ $60.29 Billion
+0.19pp
2023-12-31 0.89% €431.00 Million
≈ $503.88 Million
€48.49 Billion
≈ $56.70 Billion
+0.39pp
2022-12-31 0.50% €244.00 Million
≈ $285.26 Million
€48.53 Billion
≈ $56.74 Billion
+0.26pp
2021-12-31 0.25% €112.00 Million
≈ $130.94 Million
€45.36 Billion
≈ $53.03 Billion
+0.18pp
2020-12-31 0.07% €29.00 Million
≈ $33.90 Million
€41.80 Billion
≈ $48.86 Billion
--
pp = percentage points

About MERCK KGAA NAM.SP.ADR

F:MRKC Germany Drug Manufacturers - Specialty & Generic
Market Cap
$17.07 Billion
€14.60 Billion EUR
Market Cap Rank
#1479 Global
#329 in Germany
Share Price
€22.60
Change (1 day)
-2.59%
52-Week Range
€20.20 - €26.20
All Time High
€44.30
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more